Itacitinib for the prevention of immune effector cell therapy-associated cytokine release syndrome: Results from the phase 2 INCB 39110-211 placebo-controlled randomized cohort Meeting Abstract
| Authors: | Frigault, M. J.; Maziarz, R. T.; Park, J. H.; Lazaryan, A.; Shah, N. N.; Svoboda, J.; Lekakis, L. J.; Reshef, R.; Phillips, C. L.; Burke, L. M.; Lei, J.; Morariu-Zamfir, R.; DiPersio, J. F. |
| Abstract Title: | Itacitinib for the prevention of immune effector cell therapy-associated cytokine release syndrome: Results from the phase 2 INCB 39110-211 placebo-controlled randomized cohort |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 356 |
| Language: | English |
| ACCESSION: | WOS:001159306701113 |
| DOI: | 10.1182/blood-2023-180205 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
